ID   CAP-CD63-tGFP-Null
AC   CVCL_A8SA
DR   Wikidata; Q108819987
RX   PubMed=31461486;
CC   Characteristics: Overexpresses CD63-turboGFP. Transduced with a pStbl-CMV-bsd-CD63-tGFP vector and a pEGP-CMV-Null vector.
CC   Transfected with: HGNC; 1692; CD63.
CC   Transfected with: UniProtKB; Q6WV12; Pontellina plumata GFP2 (with p.Lys5Glu, p.Val117Met, p.Val149Asp, p.Val151Asp, p.Ala155Thr, p.Phe168Ser and p.Leu200Asp = TurboGFP).
CC   Transfected with: UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Transfected with: UniProtKB; P03281; Adenovirus 5 pIX.
CC   Transfected with: UniProtKB; P03070; SV40 large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5 [Note=E1A/E1B].
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IQ88 ! CAP
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
RX   PubMed=31461486; DOI=10.1371/journal.pone.0221679;
RA   Zeh N., Schneider H., Mathias S., Raab N., Kleemann M.,
RA   Schmidt-Hertel S., Weis B., Wissing S., Strempel N., Handrick R.,
RA   Otte K.;
RT   "Human CAP cells represent a novel source for functional, miRNA-loaded
RT   exosome production.";
RL   PLoS ONE 14:E0221679-E0221679(2019).
//